Name: First Choice Neurology
Price range: $$$

FDA Approves Leqembi, a New Alzheimer’s Drug

Alzheimer's / January 10, 2023

The FDA approved the new Alzheimer’s drug lecanemab (BAN2401), which will be sold under the brand name Leqembi developed by Eisai and Biogen last week for patients with mild cognitive

FDA Approves Leqembi, a New Alzheimer’s Drug Read More »

Leqembi

FDA Panel Recommends Full Approval for New Alzheimer’s Drug in June, Alzheimer’s & Brain Awareness Month

FDA Approves Leqembi, a New Alzheimer’s Drug

MEDICAL SERVICES

QUICK LINKS

RESOURCES